‘I’m scared about my future’: young people on the stress and desperation of jobseeking | BusinessNovember 15, 2026
General Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapyBy Healthcare Propulsion StaffNovember 11, 20260 Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies, today announced it will…
